Tyrosine kinase inhibitor sunitinib allows insulin independence in long-standing type 1 diabetes. (2014)

First Author: Huda MS
Attributed to:  MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2337/dc13-2132

PubMed Identifier: 24757248

Publication URI: http://europepmc.org/abstract/MED/24757248

Type: Journal Article/Review

Volume: 37

Parent Publication: Diabetes care

Issue: 5

ISSN: 0149-5992